Cardiovascular Adverse Events With Intravitreal Anti–Vascular Endothelial Growth Factor Drugs-Reference-Cited by-同舟云学术

Cardiovascular Adverse Events With Intravitreal Anti–Vascular Endothelial Growth Factor Drugs

Published:2021-06-01 Issue:6 Volume:139 Page:610
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Ngo Ntjam Nadège¹²³,Thulliez Marie⁴,Paintaud Gilles²³,Salvo Francesco⁵⁶,Angoulvant Denis²⁷,Pisella Pierre-Jean⁸,Bejan-Angoulvant Theodora²³

Affiliation:

1. Hospital Pharmacy, CHRU de Tours, Tours, France

2. EA 4245, T2I (Transplantation, Immunity & Inflammation), Université de Tours, Tours, France

3. Medical Pharmacology Department, CHRU de Tours, Tours, France

4. Ophthalmology Department, CHU de Montpellier, Montpellier, France

5. Medical Pharmacology Department, CHU Pellegrin, Bordeaux, France

6. Bordeaux Population Health Research Center, U1219, Université de Bordeaux, Bordeaux, France

7. Cardiology Department, CHRU de Tours, Tours, France

8. Ophthalmology Department, CHRU de Tours, Tours, France

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Link

https://jamanetwork.com/journals/jamaophthalmology/articlepdf/2778626/jamaophthalmology_ngo_ntjam_2021_oi_210016_1623191627.57199.pdf

Reference71 articles.

1. Global estimates of visual impairment: 2010.;Pascolini;Br J Ophthalmol,2012

2. Causes of vision loss worldwide, 1990-2010: a systematic analysis.;Bourne;Lancet Glob Health,2013

3. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases.;Pe’er;Lab Invest,1995

4. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema.;Nguyen;Am J Ophthalmol,2006

5. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial.;Wells;Ophthalmology,2016

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bevacizumab for Retinopathy of Prematurity is Not Associated With Systemic Hypertension;Journal of Pediatric Ophthalmology & Strabismus;2024-08-14

2. Case report: heart failure related to intravitreal injection of anti-VEGF;BMC Cardiovascular Disorders;2024-08-12

3. Cardiovascular and cerebrovascular adverse events associated with intravitreal anti-vascular endothelial growth factor monoclonal antibodies: a World Health Organization pharmacovigilance study;Ophthalmology;2024-07

4. Cardiovascular adverse events associated with immune checkpoint inhibitors: a meta-analysis;Frontiers in Immunology;2024-06-24

5. Cardiovascular risk in anti-VEGF treatment of neovascular age-related macular degeneration;Canadian Journal of Ophthalmology;2024-06